BACKGROUND: Due to budgetary restrictions our university heart transplant program came to a standstill to be gradually restarted early 2011. Consequently waiting-times for transplantation increased dramatically beyond the usual 10-15 months. We reviewed the clinical results of this peculiar transplant program over the past 4 years. METHODS: Since March 2011 until February 2015, 65 patients (age 48±23 years) were listed for heart transplantation. Eight patients (11%) of whom three in high emergency were transplanted without any form of mechanical assistance. Fifty-one patients required a left ventricular assist device (LVAD) Heartware (Heartware Inc., Miami Lakes, FL, USA) as a bridge-to-transplant due to terminal heart failure. Merely 5 listed patients remain without assistance. RESULTS: One patient without assistance and 11 LVAD patients (22%) died on the waiting-list. Meanwhile 10 LVAD patients were transplanted after a 2-year waiting time (770±717 days). Four transplanted patients died of early graft failure none after LVAD explantation. Survival at 1 and 3 years was respectively 78 (72%) and 83 (78%) for transplanted and assisted patients (log-rank P=0.056). Cox multivariable regression analysis identified crash-to-burn patients (P=0.002) and waiting-times over 2 years (P=0.044) as risk factors for early death, while age above 60 (P=0.008) and ischemic aetiology (P=0.029) and pulmonary hypertension (P=0.092) were risk factors for survival. CONCLUSIONS: In times of donor shortage mechanical assistance proves very effective as bridge-to-transplant in patients for whom candidacy follows the standard inclusion procedures. In our settings, a steep increase in LVAD implantation served to salvage patients for whom transplantation became jeopardized due to an ever increasing waiting-time. Circulatory LVAD support could be considered as primary therapy in the future.
BACKGROUND: Due to budgetary restrictions our university heart transplant program came to a standstill to be gradually restarted early 2011. Consequently waiting-times for transplantation increased dramatically beyond the usual 10-15 months. We reviewed the clinical results of this peculiar transplant program over the past 4 years. METHODS: Since March 2011 until February 2015, 65 patients (age 48±23 years) were listed for heart transplantation. Eight patients (11%) of whom three in high emergency were transplanted without any form of mechanical assistance. Fifty-one patients required a left ventricular assist device (LVAD) Heartware (Heartware Inc., Miami Lakes, FL, USA) as a bridge-to-transplant due to terminal heart failure. Merely 5 listed patients remain without assistance. RESULTS: One patient without assistance and 11 LVAD patients (22%) died on the waiting-list. Meanwhile 10 LVAD patients were transplanted after a 2-year waiting time (770±717 days). Four transplanted patients died of early graft failure none after LVAD explantation. Survival at 1 and 3 years was respectively 78 (72%) and 83 (78%) for transplanted and assisted patients (log-rank P=0.056). Cox multivariable regression analysis identified crash-to-burn patients (P=0.002) and waiting-times over 2 years (P=0.044) as risk factors for early death, while age above 60 (P=0.008) and ischemic aetiology (P=0.029) and pulmonary hypertension (P=0.092) were risk factors for survival. CONCLUSIONS: In times of donor shortage mechanical assistance proves very effective as bridge-to-transplant in patients for whom candidacy follows the standard inclusion procedures. In our settings, a steep increase in LVAD implantation served to salvage patients for whom transplantation became jeopardized due to an ever increasing waiting-time. Circulatory LVAD support could be considered as primary therapy in the future.
Entities:
Keywords:
Transplantation; bridge; explant; left ventricular assist device (LVAD); waiting-list
Authors: Ranjit John; Yoshifumi Naka; Nicholas G Smedira; Randall Starling; Ulrich Jorde; Peter Eckman; David J Farrar; Francis D Pagani Journal: Ann Thorac Surg Date: 2011-10 Impact factor: 4.330
Authors: Keith D Aaronson; Mark S Slaughter; Leslie W Miller; Edwin C McGee; William G Cotts; Michael A Acker; Mariell L Jessup; Igor D Gregoric; Pranav Loyalka; O H Frazier; Valluvan Jeevanandam; Allen S Anderson; Robert L Kormos; Jeffrey J Teuteberg; Wayne C Levy; David C Naftel; Richard M Bittman; Francis D Pagani; David R Hathaway; Steven W Boyce Journal: Circulation Date: 2012-05-22 Impact factor: 29.690
Authors: Mark S Slaughter; Francis D Pagani; Edwin C McGee; Emma J Birks; William G Cotts; Igor Gregoric; O Howard Frazier; Timothy Icenogle; Samer S Najjar; Steven W Boyce; Michael A Acker; Ranjit John; David R Hathaway; Kevin B Najarian; Keith D Aaronson Journal: J Heart Lung Transplant Date: 2013-07 Impact factor: 10.247
Authors: Angelo M Dell'Aquila; Stefan R B Schneider; Jörg Stypmann; Björn Ellger; Bassam Redwan; Dominik Schlarb; Sven Martens; Jürgen R Sindermann Journal: Artif Organs Date: 2013-10-11 Impact factor: 3.094
Authors: Ramesh S Kutty; Jayan Parameshwar; Clive Lewis; Pedro A Catarino; Catherine D Sudarshan; David P Jenkins; John J Dunning; Steven S Tsui Journal: Eur J Cardiothorac Surg Date: 2013-01-22 Impact factor: 4.191
Authors: John M Stulak; Jennifer Cowger; Jonathon W Haft; Matthew A Romano; Keith D Aaronson; Francis D Pagani Journal: Ann Thorac Surg Date: 2012-10-11 Impact factor: 4.330
Authors: Simon Maltais; Nikhil P Jaik; Irene D Feurer; Mark A Wigger; Thomas G DiSalvo; Kelly H Schlendorf; Rashid M Ahmad; Daniel J Lenihan; John M Stulak; Mary E Keebler Journal: Ann Thorac Surg Date: 2013-07-31 Impact factor: 4.330